Amanj Kurdi

4.9k total citations
137 papers, 1.8k citations indexed

About

Amanj Kurdi is a scholar working on Applied Microbiology and Biotechnology, General Health Professions and Epidemiology. According to data from OpenAlex, Amanj Kurdi has authored 137 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Applied Microbiology and Biotechnology, 45 papers in General Health Professions and 29 papers in Epidemiology. Recurrent topics in Amanj Kurdi's work include Antibiotic Use and Resistance (47 papers), Pharmaceutical Practices and Patient Outcomes (28 papers) and Pneumonia and Respiratory Infections (20 papers). Amanj Kurdi is often cited by papers focused on Antibiotic Use and Resistance (47 papers), Pharmaceutical Practices and Patient Outcomes (28 papers) and Pneumonia and Respiratory Infections (20 papers). Amanj Kurdi collaborates with scholars based in United Kingdom, Iraq and South Africa. Amanj Kurdi's co-authors include Brian Godman, R.A. Seaton, Johanna C. Meyer, Sylvia Opanga, Israel Abebrese Sefah, Jacqueline Sneddon, Reza Ghanei Gheshlagh, Marion Bennie, Natalie Schellack and Margaret Oluka and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMC Public Health.

In The Last Decade

Amanj Kurdi

123 papers receiving 1.8k citations

Peers

Countries citing papers authored by Amanj Kurdi

Since Specialization

Citations

This map shows the geographic impact of Amanj Kurdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanj Kurdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanj Kurdi more than expected).

Fields of papers citing papers by Amanj Kurdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanj Kurdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanj Kurdi. The network helps show where Amanj Kurdi may publish in the future.

Co-authorship network of co-authors of Amanj Kurdi

This figure shows the co-authorship network connecting the top 25 collaborators of Amanj Kurdi. A scholar is included among the top collaborators of Amanj Kurdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanj Kurdi. Amanj Kurdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring community pharmacy services in Gulf Cooperation Council countries: a scoping review 2025 ·International Journal of Pharmacy Practice ·(unknown), (unknown), (unknown), Amanj Kurdi	2
2	Knowledge, Attitudes, and Practices of Iraqi Parents Regarding Antibiotic Use in Children and the Implications 2025 ·Antibiotics ·(unknown), Amanj Kurdi, Marwan M. Merkhan, (unknown), Salih Ibrahem, (unknown), Johanna C. Meyer, Brian Godman	0
3	Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study 2024 ·Diabetes Obesity and Metabolism ·(unknown), Tanja Mueller, Alexander B. Mullen, Christopher Sainsbury, Gordon F. Rushworth, Amanj Kurdi	1
4	Understanding and reporting odds ratios as rate-ratio estimates in case-control studies 2023 ·Journal of Global Health ·Steven Kerr, Sander Greenland, (unknown), (unknown), Stuart Bedston, Lewis Ritchie, Colin R Simpson, Adeniyi Francis Fagbamigbe, Amanj Kurdi, Chris Robertson, Aziz Sheikh, Igor Rudan	6
5	Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis 2023 ·Expert Review of Anti-infective Therapy ·Amanj Kurdi, (unknown), (unknown), (unknown), (unknown), Tanja Mueller, R.A. Seaton, William Malcolm, Marion Bennie	2
6	Data Resource Profile: The Hospital Electronic Prescribing and Medicines Administration (HEPMA) National Data Collection in Scotland 2023 ·International Journal for Population Data Science ·Tanja Mueller, (unknown), Amanj Kurdi, (unknown), (unknown), Stuart McTaggart, Marion Bennie	0
7	Meta‐analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus 2023 ·European Journal of Clinical Investigation ·(unknown), Alexander B. Mullen, Christopher Sainsbury, Gordon F. Rushworth, (unknown), (unknown), Tanja Mueller, Amanj Kurdi	9
8	Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice 2022 ·Health Informatics Journal ·Tanja Mueller, (unknown), (unknown), (unknown), (unknown), Kimberley Kavanagh, Janet Graham, Kathryn Graham, (unknown), Robert J. Jones, Amanj Kurdi, David Morrison, Marion Bennie	2
9	The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis 2022 ·Expert Review of Clinical Pharmacology ·(unknown), (unknown), Brian Godman, Amanj Kurdi	5
10	What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma? 2022 ·Journal of Oncology Pharmacy Practice ·(unknown), Amanj Kurdi, Mandy Wilson	1
11	A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications 2022 ·Hospital Practice ·(unknown), Natalie Schellack, Brian Godman, Amanj Kurdi, Marion Bennie, (unknown), Johanna C. Meyer	15
12	Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study 2022 ·BMJ Open ·Tanja Mueller, Amanj Kurdi, Elliott C. R. Hall, (unknown), (unknown), (unknown), (unknown), (unknown), Stuart McTaggart, Marion Bennie, Aziz Sheikh	2
13	Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study 2021 ·BMJ Open ·Tanja Mueller, Steven Kerr, Stuart McTaggart, Amanj Kurdi, Eleftheria Vasileiou, Annemarie B Docherty, (unknown), Ting Shi, Colin R Simpson, Marion Bennie, Aziz Sheikh	2
14	Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa 2021 ·Hospital Practice ·(unknown), (unknown), Johanna C. Meyer, Brian Godman, Amanj Kurdi, Marilyn Lennon, Marion Bennie, Natalie Schellack	13
15	A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications 2021 ·Expert Review of Anti-infective Therapy ·(unknown), Natalie Schellack, Brian Godman, Amanj Kurdi, Marion Bennie, (unknown), Johanna C. Meyer	38
16	Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh 2021 ·Journal of Applied Pharmaceutical Science ·Farhana Akter, Mainul Haque, Francis Kalemeera, Amanj Kurdi, Brian Godman	3
17	Prevalence Rate of Spontaneously Reported Adverse Events and Determinants of Serious Adverse Events Amongst Three Outpatient Care Settings in Ghana 2021 ·SHILAP Revista de lepidopterología ·Israel Abebrese Sefah, Hope Edem Kofi Kordorwu, (unknown), Amanj Kurdi, Brian Godman	3
18	Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Amanj Kurdi	2
19	Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications 2019 ·Expert Review of Respiratory Medicine ·(unknown), Brian Godman, Amanj Kurdi, (unknown), Seán MacBride‐Stewart, (unknown), Simon Hurding, Marion Bennie, Alec Morton	6
20	Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis 2018 ·BioDrugs ·(unknown), Vânia Eloísa de Araújo, (unknown), (unknown), (unknown), (unknown), Francisco de Assis Acúrcio, Brian Godman, Amanj Kurdi, Mariângela Leal Cherchiglia, Eli Iôla Gurgel Andrade	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact